Independent research Source-backed profiles No paid rankings
Peptide Provider Direct
ACT 2 Health logo
Unclaimed8 services cataloged

ACT 2 Health

Virtual provider · Telehealth available

Visit provider website ↗

Provider overview

About ACT 2 Health

ACT 2 Health publishes a fully online, membership-led care model for adults, with biomarker review and treatment planning overseen by licensed physicians. Its current physician page names Benjamin H. Krasne, MD, Johnathan Chance Miller, MD, and Vanessa Niles, RN, MD, FACOG. The platform reports availability in all 50 states and publishes a 33-item catalog spanning compounded sermorelin, GLP-1-related weight management, men's and women's hormone care, laboratory testing, sexual wellness, and cellular-health services. ACT 2 Health states that it is a technology and administrative-services platform, while medical services are furnished through an independent professional entity and prescriptions may be dispensed by licensed pharmacies, including compounding pharmacies. This unclaimed profile records provider-published information without inferring pharmacy identity, formulation, approval, availability, safety, effectiveness, or individual eligibility.

At a glance

Market role
Telehealth platform / connector
Care model
Telehealth
Coverage
50 listed jurisdictions
Pharmacy pathway
Not publicly established

503A and 503B labels describe statutory compounding pathways or public relationships. They do not mean a compounded drug is FDA-approved or that FDA endorses a facility.

Service catalog

Programs and services

Provider-advertised services, grouped for quick scanning with all details visible.

8 cataloged
01

Peptide-related care

1

Sermorelin ODT

The current catalog lists compounded oral dissolving sermorelin, subject to clinician assessment and eligibility.

Provider source ↗
02

GLP-1 and metabolic programs

1

Semaglutide and tirzepatide weight-management programs

The platform advertises clinician-reviewed compounded injectable and oral semaglutide and tirzepatide options, with eligibility determined during clinical review.

Provider source ↗
03

Hormone health

2

Testosterone replacement therapy

ACT 2 publishes a monitored testosterone program built from laboratory results, with dosing and delivery selected with a clinician.

Provider source ↗

Hormone therapy for women

The catalog includes clinician-guided estrogen and progesterone pathways, with testosterone where clinically appropriate.

Provider source ↗
04

Laboratory services

1

Comprehensive and specialty laboratory testing

Published options include a comprehensive laboratory panel, hormone, gut, methylation, glucose-monitoring, and other specialty testing.

Provider source ↗
05

Longevity programs

1

NAD+ and cellular-health programs

The platform lists compounded NAD+ injection alongside other clinician-reviewed cellular-health offerings; this profile does not adopt promoted outcomes.

Provider source ↗
06

Sexual health

1

Sexual-wellness programs

Oxytocin and a provider-named compounded blend containing tadalafil, oxytocin, and PT-141 appear in the current catalog.

Provider source ↗
07

Care model

1

Nationwide online clinical review

ACT 2 reports online assessment, clinician review, personalized planning, home delivery when prescribed, and ongoing support in all 50 states.

Provider source ↗
Important: Inclusion does not establish availability for every patient or state, regulatory status, clinical appropriateness, safety, or effectiveness.

Coverage and research

Explore this provider’s markets

Review every state page this provider advertises serving, then use the related guides to evaluate services and claims.

Continue comparing

Related provider profiles

Evidence

Sources reviewed

Logo reproduced from the provider’s official website for identification. Logo source ↗

These links support the public facts recorded here. Provider-published information is not an independent endorsement.